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1 LMCA MI No 72 15 / 9 Improved No No Day 17 Multiorgan
failure
2 LMCA MI Yes 456 20 / 20 Improved No Yes – Left
ventricular
assist device
3 LMCA
dissection
Yes 72 Not
available
Improved Yes No Day 9 Multiorgan
failure, multiple
ischemic stroke
4 Inﬂuenza No 30 32 / 24 Improved Yes Yes – Discharged
on day 31
5 ARDS Yes 20 60 /30 Not
Improved
No No 8
hours
Multiorgan
failure
6 MI Yes 240 16 / 9 Improved Yes No 52
hours
Multiorgan
failure
LMCA ¼ Left Main Coronary Artery, MI ¼ Myocardial Infarction, ARDS ¼ Acute Respiratory
Distress Syndrome.
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Can the Aortic Wall Communicate with Us?
Calogera Pisano, Carmela Rita Balistreri, Daniele Merlo, Sara Vacirca, Giuseppe Vite,
Tommaso Delisi, Salvatore Ocello, Oreste Fabio Triolo, Vincenzo Argano, Cesira Palmeri,
Giovanni Ruvolo
University of Palermo, Palermo, Italy
Objective: Association between aortic aneurysm wall and risk of rupture or dissection.
Methods: Aortic specimens were obtained from 73 patients (51 men and 22 women,
whose median age 61.7 10.7 years) undergoing surgical repair of thoracic ascending
aneurysm (TAA). Histopathological and immunohistochemical analyses were per-
formed using adequate tissue specimens, appropriate techniques and criteria.
Furthermore, genetic risk factors were also investigated.
Results: We identiﬁed three phenotypes of TAAs with different quality of aortic wall
at the time of operation: phenotype I (normal wall); phenotype II (moderate wall
thickness); phenotype III (thin and weak wall). No signiﬁcant differences were
detected in term of demographic and clinical data, co-morbidity conditions and
pharmacological treatments. In contrast, signiﬁcant statistical differences were
observed by comparing abnormalities of extracellular matrix components among three
phenotypes (ﬁbrosis p<0.005; elastic fragmentation p¼0.002; medionecrosis
p¼0.004; cystic necrosis p¼0.07; apoptosis p<0.0001; MMP-9 amount p¼0.004). In
addition, signiﬁcant differences both in genotype distributions and allele frequencies
were observed for following SNPs (Single Nucleotide Polymorphism): -1562C/T
MMP-9 (Metalloproteinases-9), -786T/C eNOs (endothelial Nitric Oxide Synthase)
and D/I ACE (Angiotensin Converting Enzyme).
Conclusion: Aneurysm with thin and weak wall at the time of operation should seem
genetically and mainly associated with extracellular matrix disorders of aorta wall and
consequently with aorta aneurysm complications (rupture and dissection).
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The Largest Case Series of Thrombolytic Therapy for Right Sided Mechanical Pulmonic
and Tricuspid Valve Thrombosis Showing Very High Success Rate
Maryam Taherkhani,1 Reza Hashemi Hashemi,1 Manouchehr Hekmat,2 Morteza Saﬁ,1
Adineh Taherkhani,1 Mohammad Reza Movahed3
1Cardiovascular Research Center, Modarres Hospital Shahid Beheshti University, Tehran,
Iran, Islamic Republic of; 2CareMore Arizona, and University of Arizona Sarver Heart
Center, Tehran, Iran, Islamic Republic of; 3CareMore Arizona, and University of Arizona
Sarver Heart Center, Tucson, AZ
Introduction: Treatment data using thrombolytic in the setting of right sided me-
chanical valve thrombosis are almost nonexistent and all the guidelines are based on a
very small case series. The goal of this manuscript was to perform survival analysis of
larges case series of patients with right sided mechanical valve thrombosis treated with
thrombolytic therapy.
Method: We reviewed in-hospital and long term outcome data for survival analysis of
patients presenting with right sided mechanical pulmonic and tricuspid valve thrombosis
treated with thrombolytic therapy from September 2005 until Jun 2012 retrospectively.
Result: A total of 16 patients with deﬁnite thrombotic mechanical valve obstruction in
tricuspid or pulmonary position were identiﬁed (8 in pulmonary and 8 tricuspid po-
sition) who underwent thrombolytic therapy. All the patients except one had sup-
therapeutic INR. All 8 pulmonic mechanical valve thrombosis were in children with
100% respond rate to thrombolytic therapy. In hospital survival rate of pulmonic valve
thrombosis treated with thrombolytic therapy was 100%. One year survival rate of
successful treated mechanical valve pulmonic valve thrombosis was 87.5%.
Conclusion: Based on our data, we strongly recommend that thrombolytic therapy
should remain the ﬁrst line therapy for the right sided mechanical valve thrombosis in
adults or children including children with complex congenital heart disease and pa-
tients with mechanical pulmonic valve thrombosis. Surgery should be reserved for
patients who fail this treatment.CRT-727
Percutaneous Balloon Atrial Septostomy for Direct Left Heart Decompression in
Patients on Extra Corporeal Membrane Oxygenation
Pradeep K. Yadav, Giselle A. Baquero, Mark Kozak, Christoph Brehm
Pennsylvania State University, Hershey, PA
Background: Severe myocardial dysfunction and added afterload from the Extra
Corporeal Membrane Oxygenation (ECMO) arterial cannula may lead to signiﬁcant
rise in left ventricular (LV) end-diastolic and left atrial (LA) pressures. This may result
in ischemia, lower likelihood of ventricular recovery and hence raise the already high
mortality in this group. Various mechanical approaches have been suggested but
available literature in adults is limited.
Methods: We retrospectively reviewed all patients on ECMO that underwent
Percutaneous Balloon Atrial Septostomy (PBAS) for left heart decompression at our
institution over 3 years. Left heart decompression based on echocardiography, pul-
monary edema on chest radiograph and improvement in LA pressure, as well as
mortality at 30 days were analyzed.
Results: Six patients, (age 5418 years; 3 males) were identiﬁed. LA pressure
improved immediately post septostomy in 4 (80%) / 5 patients. Pulmonary edema
improved within 24 hours in 5 (83%) patients. LV decompression on echocardiog-
raphy was felt in 3 (50%) patients. Four out of six patients died due to multiorgan
failure.
Conclusion: Percutaneous Atrial Septostomy appears to decompress left heart in
patients on ECMO and profound shock. However, due to multi-organ involvement,
mortality in this critically sick group remains high.
